Janus Henderson Group PLC lessened its holdings in shares of PerkinElmer, Inc. (NYSE:PKI) by 3.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,161,489 shares of the medical research company’s stock after selling 244,187 shares during the period. Janus Henderson Group PLC owned about 5.59% of PerkinElmer worth $424,958,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in PKI. Koch Industries Inc. purchased a new position in PerkinElmer during the 2nd quarter valued at about $364,000. Assenagon Asset Management S.A. purchased a new position in PerkinElmer during the 3rd quarter valued at about $23,168,000. Robecosam AG increased its holdings in PerkinElmer by 165.7% during the 3rd quarter. Robecosam AG now owns 477,167 shares of the medical research company’s stock valued at $32,610,000 after purchasing an additional 297,595 shares during the period. Delta Lloyd Asset Management N.V. purchased a new position in PerkinElmer during the 2nd quarter valued at about $19,315,000. Finally, Vanguard Group Inc. increased its holdings in PerkinElmer by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 10,886,642 shares of the medical research company’s stock valued at $741,816,000 after purchasing an additional 273,975 shares during the period. Institutional investors own 91.66% of the company’s stock.
PKI has been the topic of a number of research analyst reports. Cowen restated a “hold” rating and set a $70.00 price target on shares of PerkinElmer in a report on Friday, September 1st. Citigroup reiterated a “buy” rating and set a $80.00 target price (up previously from $74.00) on shares of PerkinElmer in a report on Tuesday, September 26th. Goldman Sachs Group reiterated a “neutral” rating and set a $67.00 target price on shares of PerkinElmer in a report on Tuesday, September 26th. Morgan Stanley reiterated an “overweight” rating and set a $77.00 target price (down previously from $79.00) on shares of PerkinElmer in a report on Friday, October 6th. Finally, Robert W. Baird reiterated a “buy” rating and set a $72.00 target price on shares of PerkinElmer in a report on Friday, October 20th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $68.64.
In related news, Director Alexis P. Michas sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $73.18, for a total value of $365,900.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Frank Anders Wilson sold 37,535 shares of the company’s stock in a transaction that occurred on Thursday, December 7th. The shares were sold at an average price of $70.14, for a total value of $2,632,704.90. The disclosure for this sale can be found here. Over the last three months, insiders sold 73,656 shares of company stock worth $5,201,957. Insiders own 2.20% of the company’s stock.
Shares of PerkinElmer, Inc. (NYSE PKI) traded up $0.92 on Friday, hitting $71.03. The stock had a trading volume of 739,669 shares, compared to its average volume of 605,188. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.09 and a current ratio of 2.59. PerkinElmer, Inc. has a 12-month low of $50.59 and a 12-month high of $74.11. The company has a market cap of $7,727.89, a PE ratio of 25.22, a P/E/G ratio of 2.10 and a beta of 0.77.
The business also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Friday, January 19th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.39%. PerkinElmer’s dividend payout ratio is currently 7.78%.
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.